… Nobel Prize in Physiology or Medicine 2025 for their discoveries … with Fred Ramsdell at a biotech company in Seattle. They … at Sonoma Biotherapeutics, a biotechnology company co-founded by him … the Faculty of Medicine and Graduate School of Medicine of Kyoto …

… oncology, neurology, and metabolic medicine. By identifying precise molecular … a regional hub for precision medicine. Its modernized Biobank Center … The rise of genomic medicine at KFSHRC reflects a … only a consumer of biotechnology but a producer of …

… high-growth companies, including Revolution Medicines, Akero Therapeutics, and Scholar Rock … its innovation-driven portfolio, BB Biotech considers itself ideally positioned to … The takeaway from Switzerland’s biotech investment specialist is clear: innovation …

… global body of space medicine research but also laid … aimed at deepening cooperation in biotechnology, astronaut health, and education … injury, and refine preventive medicine strategies. Space has become … expand what is possible in medicine. And for KFSHRC, …

… pharmaceuticals, specialty chemicals, and biotechnology. Achievements and Expertise With … for leadership in industrial biotechnology, developing novel bioprocesses for … into AI-integrated precision medicine, industrial biotech, and genomics continues to …

… definitive agreement to acquire Aderum Biotechnologies and its leading candidate Ixo … , development, and commercialization of innovative medicines for chronic and age-related … chief executive officer of Adverum Biotechnologies. "We share Lilly…

Biogen is putting more than $1 billion on the table for rights to an experimental, immune system-regulating drug that has yet to enter human testing. Through a deal announced Friday, Biogen will pay privately held Vanqua Bio $70 million up front for …

Today, a brief rundown of news from Chugai Pharmaceutical and ICER, as well as updates from Arcturus Therapeutics, Summit Therapeutics and Terns Pharmaceuticals that you may have missed. Chugai Pharmaceutical will pay 15 billion yen, or about $98 million, …

… agents, antibiotics, and other lifesaving medicines. These disruptions stem not from … the FDA’s Office of Biotechnology.

… intelligence (AI) is transforming biotechnology, from accelerating drug discovery and … -focused biotech startups is increasing, with firms like Insilico Medicine, Deep … interoperability, and global collaboration in biotech research. Meanwhile, companies are …